| abstract |
The present invention provides a 3,7-diazabicyclo [3,3,1] nonane compound in the form of a liquid pharmaceutical formulation, preferably 9,9-alkylene-3,7-diazabicyclo [3,3 Nonane compounds, most preferably teddysamyl, and physiologically acceptable acid addition salts and / or solvates thereof, for treating and / or preventing anti-arrhythmic attacks in patients, preferably the recently disclosed atrium Fibrillation, or Fibrillation, relates to use to improve a patient's normal dynamic heartbeat (NSR). The invention also relates to methods of treatment and pharmaceutical products. |